121 related articles for article (PubMed ID: 34582697)
1. Clinical Significance and Underlying Mechanisms of CELSR3 in Metastatic Prostate Cancer Based on Immunohistochemistry, Data Mining, and
Sun Y; Chen G; He J; Li JX; Gan XY; Ji SF; Huang Y; Chen XH; He ML; Huang ZG
Cancer Biother Radiopharm; 2022 Aug; 37(6):466-479. PubMed ID: 34582697
[No Abstract] [Full Text] [Related]
2. Clinical significance and potential molecular mechanism of miRNA-222-3p in metastatic prostate cancer.
Sun Y; Chen G; He J; Huang ZG; Li SH; Yang YP; Zhong LY; Ji SF; Huang Y; Chen XH; He ML; Wu H
Bioengineered; 2021 Dec; 12(1):325-340. PubMed ID: 33356818
[TBL] [Abstract][Full Text] [Related]
3. The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer.
Van Emmenis L; Ku SY; Gayvert K; Branch JR; Brady NJ; Basu S; Russell M; Cyrta J; Vosoughi A; Sailer V; Alnajar H; Dardenne E; Koumis E; Puca L; Robinson BD; Feldkamp MD; Winkis A; Majewski N; Rupnow B; Gottardis MM; Elemento O; Rubin MA; Beltran H; Rickman DS
Cancer Res Commun; 2023 Aug; 3(8):1447-1459. PubMed ID: 37546702
[TBL] [Abstract][Full Text] [Related]
4. Elevated CELSR3 expression is associated with hepatocarcinogenesis and poor prognosis.
Ouyang X; Wang Z; Yao L; Zhang G
Oncol Lett; 2020 Aug; 20(2):1083-1092. PubMed ID: 32724347
[TBL] [Abstract][Full Text] [Related]
5. High expression of centromere protein A and its molecular mechanism and clinical significance in prostate cancer: A study based on data mining and immunohistochemistry.
Jiang FC; Zhai GQ; Liu JL; Wang RG; Yang YP; Murugesan H; Yu XX; Du XF; He J; Feng ZB; Pan SL; Chen G; Li SH; Huang ZG
IET Syst Biol; 2023 Oct; 17(5):245-258. PubMed ID: 37488766
[TBL] [Abstract][Full Text] [Related]
6. Systematic expression analysis of the CELSR family reveals the importance of CELSR3 in human lung adenocarcinoma.
Li Y; Zhu L; Hao R; Li Y; Zhao Q; Li S
J Cell Mol Med; 2021 May; 25(9):4349-4362. PubMed ID: 33811453
[TBL] [Abstract][Full Text] [Related]
7. miR-1-3p/CELSR3 Participates in Regulating Malignant Phenotypes of Lung Adenocarcinoma Cells.
Miao H; Zeng Q; Xu S; Chen Z
Curr Gene Ther; 2021; 21(4):304-312. PubMed ID: 34139980
[TBL] [Abstract][Full Text] [Related]
8. Involvement of CELSR3 Hypermethylation in Primary Oral Squamous Cell Carcinoma.
Khor GH; Froemming GR; Zain RB; Abraham TM; Lin TK
Asian Pac J Cancer Prev; 2016; 17(1):219-23. PubMed ID: 26838213
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of CELSR3 indicates a poor prognostic factor for Prostate Cancer.
Chen X; Ma Q; Liu Y; Li H; Liu Z; Zhang Z; Niu Y; Shang Z
J Cancer; 2021; 12(4):1115-1124. PubMed ID: 33442409
[No Abstract] [Full Text] [Related]
10. CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis.
Gu X; Li H; Sha L; Mao Y; Shi C; Zhao W
PeerJ; 2019; 7():e7816. PubMed ID: 31608178
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of the planar cell polarity genes CELSR3 and FZD3 in Hirschsprung disease.
Su L; Zhang Z; Gan L; Jiang Q; Xiao P; Zou J; Li Q; Jiang H
Exp Mol Pathol; 2016 Oct; 101(2):241-248. PubMed ID: 27619161
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miRNA-205 Expression and Biological Mechanism in Prostate Cancer Tumorigenesis and Bone Metastasis.
Sun Y; Li SH; Cheng JW; Chen G; Huang ZG; Gu YY; Yan HB; He ML
Biomed Res Int; 2020; 2020():6037434. PubMed ID: 33178832
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
[TBL] [Abstract][Full Text] [Related]
14. miR-425-5p as an exosomal biomarker for metastatic prostate cancer.
Rode MP; Silva AH; Cisilotto J; Rosolen D; Creczynski-Pasa TB
Cell Signal; 2021 Nov; 87():110113. PubMed ID: 34371055
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
16. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
[TBL] [Abstract][Full Text] [Related]
17. Potential involvement of mi-RNA 574-3p in progression of prostate cancer: A bioinformatic study.
Ashraf NM; Imran K; Kastner DW; Ikram K; Mushtaq A; Hussain A; Zeeshan N
Mol Cell Probes; 2017 Dec; 36():21-28. PubMed ID: 28734841
[TBL] [Abstract][Full Text] [Related]
18. Effect of CELSR3 on the Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells.
Xie Z; Dang Y; Wu H; He R; Ma J; Peng Z; Rong M; Li Z; Yang J; Jiang Y; Chen G; Yang L
J Cancer; 2020; 11(10):2830-2844. PubMed ID: 32226501
[TBL] [Abstract][Full Text] [Related]
19. Exploration and validation of downregulated microRNA-199a-3p, downstream messenger RNA targets and transcriptional regulation in osteosarcoma.
Huang WT; Liu AG; Cai KT; He RQ; Li Z; Wei QJ; Chen MY; Huang JY; Yan WY; Zhou H; Chen G; Ma J
Am J Transl Res; 2019; 11(12):7538-7554. PubMed ID: 31934299
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
